المؤلفون: Garima Jain, Chandan Kumar, Anita Chopra

المصدر: BMJ Case Rep

مصطلحات موضوعية: 0301 basic medicine, Pathology, medicine.medical_specialty, Images In…, business.industry, Myeloid leukemia, General Medicine, 030105 genetics & heredity, Peripheral blood, 03 medical and health sciences, Leukemia, Myeloid, Acute, 0302 clinical medicine, medicine.anatomical_structure, hemic and lymphatic diseases, medicine, Humans, Bone marrow, business, 030217 neurology & neurosurgery

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43826bcc24ef039903ba913272274553
https://pubmed.ncbi.nlm.nih.gov/33962914

المؤلفون: Stuart Peacock, Corneliu Bolbocean, Aly Karsan, Dean A. Regier, Donna E. Hogge, Sonya Cressman, Emily McPherson

المصدر: British Journal of Haematology

مصطلحات موضوعية: Oncology, Adult, medicine.medical_specialty, Canada, Cost effectiveness, medicine.medical_treatment, Cost-Benefit Analysis, intermediate‐risk AML, Gene mutation, Decision Support Techniques, 03 medical and health sciences, Young Adult, 0302 clinical medicine, Quality of life, Recurrence, Risk Factors, Internal medicine, Cost‐effectiveness, medicine, Humans, Economic impact analysis, health care economics and organizations, Retrospective Studies, Chemotherapy, business.industry, Haematological Malignancy, Mortality rate, Remission Induction, Hematopoietic Stem Cell Transplantation, Hematology, Genomics, Middle Aged, Surgery, Transplantation, Leukemia, Myeloid, Acute, Treatment Outcome, genomic analysis, 030220 oncology & carcinogenesis, first remission treatment, Quality-Adjusted Life Years, Myeloid leukaemia, business, 030215 immunology, Research Paper

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98ed6e2cf624c367fbba849d92e9bd37
https://doi.org/10.1111/bjh.14076

المؤلفون: Giebel, Sebastian, Labopin, Myriam, Sobczyk-Kruszelnicka, Malgorzata, Stelljes, Matthias, Byrne, Jenny, Fegueux, Nathalie, Beelen, Dietrich, Rovira, Montserrat, Spyridonidis, Alexandros, Blaise, Didier, Bornhäuser, Martin, Karadogan, Ihsan, Savani, Bipin, Nagler, Arnon, Mohty, Mohamad, Martin, Sonja, Chevallier, Patrice, Neubauer, Andreas, Damaj, Gandhi, Koc, Yener, Ganser, Arnold, Collin, Matthew, Yakoub-Agha, Ibrahim, Ozdogu, Hakan, Araujo, Mercedes Colorado, Itäla-Remes, Maija, Orchard, Kim, Isaksson, Cecilia, Bethge, Wolfgang, Martin, Hans, Aljurf, Mahmoud, Faber, Edgar, Caballero, Dolores, Zák, Pavel, Leleu, Xavier, Bay, Jacques-Olivier, Rohrlich, Pierre-Simon, Kröger, Nicolaus, Huynh, Anne, Schäfer-Eckart, Kerstin, Milpied, Noel, Lenhoff, Stig, Ho, Aloysius, López, Jose Luis Bello, Mordini, Nicola, Lioure, Bruno, Halaburda, Kazimierz, Olivieri, Attilio, Gedde-Dahl, Tobias, Protheroe, Rachel, Tischer, Johanna, Klammer, Matthias, Clausen, Johannes, Potter, Victoria, Ladetto, Marco, Tilly, Herve, Deconinck, Eric, Brecht, Arne, Müller, Lutz Peter, Heinicke, Thomas, Carrete, Juan Pio Torres, Bazarbachi, Ali, Reményi, Péter, Rubio, Marie Thérèse, Fanin, Renato, Pérez-Simón, Jose Antonio, Niels, Murawski, Diez-Martin, J., Arat, Mutlu, Hermine, Olivier, Socié, Gerard, Cornelissen, Jan, Santarone, Stella, Guyotat, Denis, Bulabois, Claude Eric, Bernasconi, Paolo, Johansson, Jan-Erik, Vrhovac, Radovan, Greinix, Hildegard, Lorenzo, José Luis López, Apte, Shashikant, Craddock, Charles, Kobbe, Guido, Zahrani, Mohsen Al, Dreger, Peter, Lange, Andrzej, Tbakhi, Abdelghani, Meijer, Ellen, Llamas, Carlos Vallejo, Santasusana, Josep Maria Ribera, Corradini, Paolo, Benedetti, Fabio, Rambaldi, Alessandro, Gandemer, Virginie, Malfuson, Jean-Valère, Kaare, Ain, Risitano, Antonio, Petrini, Mario, Selleri, Carmine, Wu, Depei

المساهمون: Hematology, CCA - Cancer Treatment and quality of life, Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC), Centre de Recherche en Cancérologie de Marseille (CRCM), Aix Marseille Université (AMU)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)

المصدر: Bone Marrow Transplantation, 56(2), 481-491. Nature Publishing Group
Giebel, S, Labopin, M, Sobczyk-Kruszelnicka, M, Stelljes, M, Byrne, J L, Fegueux, N, Beelen, D W, Rovira, M, Spyridonidis, A, Blaise, D, Bornhäuser, M, Karadogan, I, Savani, B N, Nagler, A, Mohty, M & Principal investigators of the contributing institutions 2021, ' Total body irradiation + fludarabine compared to busulfan + fludarabine as “reduced-toxicity conditioning” for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation in first complete remission: a study by the Acute Leukemia Working Party of the EBMT ', Bone Marrow Transplantation, vol. 56, no. 2, pp. 481-491 . https://doi.org/10.1038/s41409-020-01050-7
Bone Marrow Transplantation
Bone Marrow Transplantation, 2021, 56 (2), pp.481-491. ⟨10.1038/s41409-020-01050-7⟩

مصطلحات موضوعية: medicine.medical_specialty, Transplantation Conditioning, MESH: Busulfan, Medizin, MESH: Graft vs Host Disease, Graft vs Host Disease, [SDV.CAN]Life Sciences [q-bio]/Cancer, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Humans, Busulfan, MESH: Hematopoietic Stem Cell Transplantation, MESH: Transplantation Conditioning, Retrospective Studies, Transplantation, Acute leukemia, MESH: Humans, MESH: Middle Aged, business.industry, Hazard ratio, Hematopoietic Stem Cell Transplantation, Myeloid leukemia, MESH: Retrospective Studies, Retrospective cohort study, Hematology, Middle Aged, Total body irradiation, Fludarabine, Leukemia, Myeloid, Acute, Regimen, 030220 oncology & carcinogenesis, MESH: Vidarabine, [SDV.IMM]Life Sciences [q-bio]/Immunology, MESH: Leukemia, Myeloid, Acute, business, MESH: Whole-Body Irradiation, Vidarabine, Whole-Body Irradiation, 030215 immunology, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a271bda3480115a5c698ba5b59f0ad1
https://doi.org/10.1038/s41409-020-01050-7

المؤلفون: Cih En Huang, Ming Yao, Cheng Hsien Lin, Ming Sun Yu, Ping Ying Chang, Su-Peng Yeh, Yi-Chang Liu, Jyh Pyng Gau, Chi Cheng Li, Tran Der Tan, Sheng Hsuan Chien, Sin Syue Li, Po Nan Wang

المصدر: Journal of the Formosan Medical Association, Vol 120, Iss 12, Pp 2144-2152 (2021)

مصطلحات موضوعية: Oncology, Medicine (General), medicine.medical_specialty, Transplantation Conditioning, medicine.medical_treatment, Comorbidity, Hematopoietic stem cell transplantation, Disease, Cohort Studies, 03 medical and health sciences, R5-920, 0302 clinical medicine, Elderly adult, immune system diseases, hemic and lymphatic diseases, Internal medicine, Humans, Medicine, Aged, Retrospective Studies, Acute leukemia, business.industry, Hazard ratio, Hematopoietic Stem Cell Transplantation, Myeloid leukemia, Retrospective cohort study, General Medicine, Transplantation, Leukemia, Myeloid, Acute, surgical procedures, operative, Myelodysplastic Syndromes, 030220 oncology & carcinogenesis, Allogeneic hematopoietic stem cell transplantation, 030211 gastroenterology & hepatology, Charlson comorbidity index, business, Myelodysplastic syndrome, Cohort study

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d95eac2231cb05e728f81fd9679de8f
https://doi.org/10.1016/j.jfma.2020.12.021

المؤلفون: Salah Aref, Shaimaa El-Ashwah, Mohamed El Agdar, Lamiaa Ebrahim, Mohamed Ayed

المصدر: Cancer Biomarkers. 32:263-270

مصطلحات موضوعية: Male, Oncology, Cancer Research, medicine.medical_specialty, Stromal cell, Cohort Studies, 03 medical and health sciences, 0302 clinical medicine, Text mining, Downregulation and upregulation, Bone Marrow, hemic and lymphatic diseases, Internal medicine, Gene expression, Biomarkers, Tumor, Genetics, medicine, Humans, Prospective Studies, business.industry, Myeloid leukemia, General Medicine, medicine.disease, Chemokine CXCL12, Activins, Leukemia, Myeloid, Acute, Leukemia, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Biomarker (medicine), Female, Bone marrow, business, 030215 immunology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51c0964920a0c83df6709510f47aa012
https://doi.org/10.3233/cbm-203171

المؤلفون: Suman Kambhampati, Iskra Pusic, James M. Foran, John G. Edwards, John Lister, Farhad Ravandi, John M. Pagel, Charalambos Andreadis, Camille N. Abboud, Swapna Panuganti, Lois Kellerman, Martin S. Tallman, Richard David Mamelok, Delong Liu, Lawrence E. Morris, Saar Gill, Alicia Wong, Jack W. Hsu, Gary J. Schiller, Pinkal Desai, Hagop M. Kantarjian, Melham M. Solh, Irum Khan, Olga Frankfurt, Rodney Van Syoc, Patrick J. Stiff, Ramkumar Mandalam, Janice M. Brown, Wendy Stock, Luke P. Akard, Celalettin Ustun, Matthew J Wieduwilt

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol 39, iss 29

مصطلحات موضوعية: Male, Myeloid, Cancer Research, Antifungal Agents, Neutrophils, 030204 cardiovascular system & hematology, law.invention, 0302 clinical medicine, Randomized controlled trial, law, Granulocyte Colony-Stimulating Factor, Cytotoxic T cell, Prospective Studies, Cancer, Leukemia, Myeloid leukemia, Induction Chemotherapy, Hematology, Middle Aged, Leukemia, Myeloid, Acute, Infectious Diseases, medicine.anatomical_structure, Oncology, 6.1 Pharmaceuticals, 030220 oncology & carcinogenesis, Female, Open label, Infection, Adult, Clinical Trials and Supportive Activities, Clinical Sciences, Oncology and Carcinogenesis, Acute, Neutropenia, 03 medical and health sciences, Rare Diseases, Clinical Research, medicine, Humans, Oncology & Carcinogenesis, Myeloid Progenitor Cells, Aged, Progenitor, business.industry, Evaluation of treatments and therapeutic interventions, Induction chemotherapy, medicine.disease, Cancer research, business

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0ffcaa3359e72993b55cfac9f54aba1
https://doi.org/10.1200/jco.20.01739

المؤلفون: Yael Berda-Haddad, Laure Farnault, Mourad Hamimed, Joseph Ciccolini, Geoffroy Venton, Régis Costello, L'Houcine Ouafik, Mélanie Donnette, Raphaelle Fanciullino, Elise Kaspi, Bruno Lacarelle

المساهمون: Méthodes computationnelles pour la prise en charge thérapeutique en oncologie : Optimisation des stratégies par modélisation mécaniste et statistique (COMPO), Inria Sophia Antipolis - Méditerranée (CRISAM), Institut National de Recherche en Informatique et en Automatique (Inria)-Institut National de Recherche en Informatique et en Automatique (Inria)-Centre de Recherche en Cancérologie de Marseille (CRCM), Aix Marseille Université (AMU)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Aix Marseille Université (AMU)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Simulation and Modeling of Adaptive Response for Therapeutics in Cancer (SMARTc), Centre de Recherche en Cancérologie de Marseille (CRCM), Hôpital de la Conception [CHU - APHM] (LA CONCEPTION), Laboratoire de Biologie Cellulaire [Hôpital de la Timone - APHM], Assistance Publique - Hôpitaux de Marseille (APHM)-Hôpital de la Timone [CHU - APHM] (TIMONE), Hôpital Nord [CHU - APHM], Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Aix Marseille Université (AMU), Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital de la Timone [CHU - APHM] (TIMONE)

المصدر: Journal of Controlled Release
Journal of Controlled Release, Elsevier, 2021, 338, pp.244-252. ⟨10.1016/j.jconrel.2021.08.023⟩
Journal of Controlled Release, 2021, 338, pp.244-252. ⟨10.1016/j.jconrel.2021.08.023⟩

مصطلحات موضوعية: Adult, Daunorubicin, [SDV]Life Sciences [q-bio], Pharmaceutical Science, Pharmacology, 030226 pharmacology & pharmacy, 03 medical and health sciences, 0302 clinical medicine, Pharmacokinetics, Humans, Medicine, ComputingMilieux_MISCELLANEOUS, business.industry, Cytarabine, Myeloid leukemia, [SDV.SP]Life Sciences [q-bio]/Pharmaceutical sciences, medicine.disease, 3. Good health, Leukemia, Myeloid, Acute, medicine.anatomical_structure, Pharmacogenetics, [SDV.TOX]Life Sciences [q-bio]/Toxicology, 030220 oncology & carcinogenesis, Toxicity, Bone marrow, business, Febrile neutropenia, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75875ad29d5121e87a16bffc6a94cc84
https://doi.org/10.1016/j.jconrel.2021.08.023

المؤلفون: Rasha Mahmoud Allam, Nevine F. Shafik, Ghada M. Elsayed, Amira Darwish

المصدر: Clinical Lymphoma Myeloma and Leukemia. 21:676-685

مصطلحات موضوعية: Male, Oncology, Cancer Research, medicine.medical_specialty, NPM1, Prognostic factor, 03 medical and health sciences, 0302 clinical medicine, Gene Frequency, hemic and lymphatic diseases, Internal medicine, medicine, Humans, Allele, Gene, Allele frequency, business.industry, Myeloid leukemia, hemic and immune systems, Hematology, Prognosis, body regions, Leukemia, Myeloid, Acute, Treatment Outcome, fms-Like Tyrosine Kinase 3, 030220 oncology & carcinogenesis, embryonic structures, Fms-Like Tyrosine Kinase 3, Female, business, psychological phenomena and processes, 030215 immunology, Flt3 itd

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d87d7fcd354278cb790ffaf7406aef77
https://doi.org/10.1016/j.clml.2021.05.005

المؤلفون: François Lifermann, Jean-Alain Martignoles, Anne Quinquenel, Vincent Parinet, Christine Lefebvre, Pierre Hirsch, Mélanie Martin, Sabine Defasque, Florence Nguyen-Khac, Matthieu Decamp, Laurence Simon, Dominique Penther, Nadia Ali-Ammar, Elise Chapiro, Odile Maarek, Chrystele Bilhou-Nabera, Baptiste Gaillard, Agathe Maillon, Jean-Baptiste Micol, Marine Baron, Nathalie Auger, Stéphanie Struski, Damien Roos-Weil, Sylvie Tondeur, Marie-Joelle Mozziconacci, Audrey Bidet

المساهمون: Service d'Hématologie clinique [CHU Pitié-Salpêtrière], CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Service de Génétique Cytogénétique et Embryologie [CHU Pitié-Salpêtrière], Centre de Recherche des Cordeliers (CRC (UMR_S_1138 / U1138)), École pratique des hautes études (EPHE), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Université de Paris (UP), Hôpital Haut-Lévêque [CHU Bordeaux], CHU Bordeaux [Bordeaux], Hôpital Robert Debré, Service d'Hémato-oncologie [CHU Saint-Louis], Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre Hospitalier Universitaire [Grenoble] (CHU), Laboratoire CERBA [Saint Ouen l'Aumône], Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC), Centre Hospitalier Universitaire de Reims (CHU Reims), Service de Génétique [CHU Caen], CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Université de Caen Normandie (UNICAEN), Normandie Université (NU), Centre Hospitalier de Dax, Hôpital Universitaire Carémeau [Nîmes] (CHU Nîmes), Centre Hospitalier Universitaire de Nîmes (CHU Nîmes), Institut Universitaire du Cancer de Toulouse - Oncopole (IUCT Oncopole - UMR 1037), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-CHU Toulouse [Toulouse]-Institut National de la Santé et de la Recherche Médicale (INSERM), Génomique et Médecine Personnalisée du Cancer et des Maladies Neuropsychiatriques (GPMCND), Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Normandie Université (NU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Département d'hématologie [Gustave Roussy], Institut Gustave Roussy (IGR), Génétique (Biologie pathologie), Département de biologie et pathologie médicales [Gustave Roussy], Institut Gustave Roussy (IGR)-Institut Gustave Roussy (IGR), CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Centre de Recherche Saint-Antoine (CR Saint-Antoine), Sorbonne Université (SU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Saint-Antoine [AP-HP], Service d'immunologie et hématologies biologiques [CHU Saint-Antoine], Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Université Paris Cité (UPCité), Centre de Recherche en Cancérologie de Marseille (CRCM), Aix Marseille Université (AMU)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Université de Caen Normandie (UNICAEN), Normandie Université (NU)-Normandie Université (NU)-CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Tumorothèque de Caen Basse-Normandie (TCBN), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre de Recherche Saint-Antoine (CRSA), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), HAL-SU, Gestionnaire, École Pratique des Hautes Études (EPHE), Université de Toulouse (UT)-Université de Toulouse (UT)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Institut National de la Santé et de la Recherche Médicale (INSERM)

المصدر: Journal of Cellular and Molecular Medicine
Journal of Cellular and Molecular Medicine, Wiley Open Access, 2021, ⟨10.1111/jcmm.16895⟩
Journal of Cellular and Molecular Medicine, 2021, ⟨10.1111/jcmm.16895⟩

مصطلحات موضوعية: Male, Oncology, Myeloid, [SDV]Life Sciences [q-bio], Chromosomal translocation, Translocation, Genetic, chemistry.chemical_compound, 0302 clinical medicine, hemic and lymphatic diseases, 12), In Situ Hybridization, Fluorescence, Aged, 80 and over, CHIC2, Middle Aged, Immunohistochemistry, 3. Good health, [SDV] Life Sciences [q-bio], Leukemia, Myeloid, Acute, medicine.anatomical_structure, RUNX1, 030220 oncology & carcinogenesis, Cytogenetic Analysis, Cohort, Molecular Medicine, Female, Original Article, Chromosomes, Human, Pair 4, medicine.medical_specialty, IDH1, 03 medical and health sciences, Internal medicine, Biomarkers, Tumor, medicine, Humans, Genetic Predisposition to Disease, acute myeloid leukaemia, Genetic Association Studies, Aged, Chromosome Aberrations, Chromosomes, Human, Pair 12, Myeloproliferative Disorders, business.industry, Myelodysplastic syndromes, Original Articles, ETV6, Cell Biology, medicine.disease, myelodysplastic syndrome, t(4, chemistry, Fusion transcript, Myelodysplastic Syndromes, prognosis, business, 030215 immunology

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe78251afab09f3dfc0a82b33aef0f3b
https://doi.org/10.1111/jcmm.16895

المؤلفون: Eunice S. Wang, Nicholas J. Short, Guido Marcucci, Amir T. Fathi, Hagop M. Kantarjian, Andrew H. Wei, Martin S. Tallman, Farhad Ravandi

المصدر: Clinical Lymphoma Myeloma and Leukemia. 21:580-597

مصطلحات موضوعية: Male, Cancer Research, medicine.medical_specialty, Time Factors, medicine.medical_treatment, Treatment outcome, Targeted therapy, Food and drug administration, 03 medical and health sciences, 0302 clinical medicine, hemic and lymphatic diseases, medicine, Humans, Intensive care medicine, neoplasms, Aged, business.industry, Perspective (graphical), Myeloid leukemia, Hematology, Middle Aged, Prognosis, Leukemia, Myeloid, Acute, Treatment Outcome, Oncology, 030220 oncology & carcinogenesis, Female, business, 030215 immunology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bed4117b8d970681969db1e4f3dbbe7
https://doi.org/10.1016/j.clml.2021.05.016